JS Link

JS Link FCF Growth

The Year-over-Year Free Cash Flow Growth of JS Link (127120.KQ) as of Oct 26, 2026 is -127.56 %. In the previous year, Year-over-Year Free Cash Flow Growth was -197.22 % — a change of -35.32% (higher).

FCF Growth

-127.56 %

YoY

-35.32%

Last updated:

Year-over-Year Free Cash Flow Growth of JS Link is 2025 -127.56 % . Year-over-Year Free Cash Flow Growth of JS Link was 2024 -197.22 % . It decreases by -35.32% higher compared to the previous year.

The JS Link FCF Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Growth
Date
FCF Growth
Jan 1, 2018
-26.93 KRW
Jan 1, 2019
5.85 KRW
Jan 1, 2020
93.58 KRW
Jan 1, 2021
-4,100.70 KRW
Jan 1, 2022
61.51 KRW
Jan 1, 2023
-96.59 KRW
Jan 1, 2024
-197.22 KRW
Jan 1, 2025
-127.56 KRW
The JS Link FCF Growth history
YEARFCF GrowthYoY
-127.56 %-35.32%
-197.22 %+104.18%
-96.59 %-257.03%
61.51 %-101.50%
-4,100.70 %-4,481.93%
93.58 %+1,499.09%
5.85 %-121.73%
-26.93 %-173.52%
36.63 %+23.37%
29.69 %-108.14%
-364.60 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

JS Link Stock analysis

What does JS Link do? DNA Link, Inc. generates revenue through its genomic analysis services and products. The company offers genome biomarkers excavation products via the enhanced genome integration system (EGIS) brand, which includes high-quality data products, genomic analysis interpretation, and molecular diagnostic kit production technologies. Additionally, DNA Link provides personal genome analysis services under the deoxyribonucleic acid personalized services (DNAGPS) brand, targeting individuals seeking personalized genetic insights. The primary customers for EGIS are healthcare providers and research institutions requiring integrated genomic and clinical data solutions, while DNAGPS serves individual consumers interested in personalized health information. The enhanced genome integration system (EGIS) brand focuses on delivering comprehensive genomic analysis and clinical information integration, catering to the needs of medical professionals and research organizations. DNAGPS targets individual users who want detailed personal genome reports. Both product lines leverage DNA Link's expertise in genomic analysis and molecular diagnostics, ensuring high-quality data and interpretation services. The company's revenue streams are driven by the sale of these branded products to their respective target segments. DNA Link's business model centers around two core product lines: EGIS for professional and institutional clients and DNAGPS for individual consumers. EGIS products are sold to healthcare providers and research institutions that require advanced genomic data analysis and molecular diagnostic solutions. DNAGPS services are marketed directly to consumers seeking personalized genetic information. The company's revenue is derived from the licensing and sale of these branded genomic analysis services and products, with no mention of additional revenue sources in the business description. JS Link is one of the most popular companies on Eulerpool.

Frequently Asked Questions about JS Link stock

Year-over-Year Free Cash Flow Growth of JS Link is -127.56 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year Free Cash Flow Growth JS Link since 2006 – with annual values, charts, and detailed analysis.

FCF growth measures the percentage change in free cash flow. Growing FCF indicates improving cash generation capability.

To evaluate Year-over-Year Free Cash Flow Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Free Cash Flow Growth.

Year-over-Year Free Cash Flow Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Free Cash Flow Growth's JS Link historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — JS Link

All Key Metrics — JS Link